Clinical Trial Update: Phase I/Ib Multiple Ascending Dose Study in China [Phase 1]

View source ↗

Summary

Phase I/Ib multiple ascending dose trial in China for metastatic solid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Metastatic Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2024-02-23